DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.
about
Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidineA decade of exploring the cancer epigenome - biological and translational implicationsEpigenetic regulators and their impact on therapy in acute myeloid leukemiaA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsMyelodysplastic syndromes: what do hospitalists need to know?DNA demethylation and invasive cancer: implications for therapeuticsGadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascadesVorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanismsSuberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.Demethylating Agents in the Treatment of CancerRoles of retrotransposons in benign and malignant hematologic disease.Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomasEpigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.A recombinant reporter system for monitoring reactivation of an endogenously DNA hypermethylated gene.Current therapy of myelodysplastic syndromesEradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.DNA methylation of cancer genome.A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationMyelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells.Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer.Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancerDecitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts.Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.Targeting Histone Deacetylases in Diseases: Where Are We?Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.Methylation Profiling of Multiple Tumor Suppressor Genes in Hepatocellular Carcinoma and the Epigenetic Mechanism of 3OST2 RegulationMLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.Current knowledge on pancreatic cancer.Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancerMethylation of TFPI-2 is an early event of esophageal carcinogenesisPredictive and prognostic factors in colorectal cancer: a personalized approach.Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies.Changing the treatment paradigm in myelodysplastic syndromes.Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research
P2860
Q24608659-ABA1799F-E9A8-4D89-8F38-2FADE22E41A5Q24614467-1436E46D-653D-453F-8671-3E38219672E5Q26765402-0F17DC7E-C0DF-4957-8315-AA83D80ED44FQ26852571-24C01954-E84E-431A-9E64-8882CA12B4CAQ27011372-988C7D63-E2B7-46CA-8170-CA9C79D903F7Q27011914-FAA1E9AA-AA07-456E-A02A-E4823E0B4D08Q28388105-4F91001E-3E6E-435F-8F67-DD3E256B9A3FQ28484904-970FE642-0C5A-46FB-BC93-73CF41104D59Q30303153-904CE270-F152-435A-902C-8946E07C4CA9Q33678040-7CB9E863-9D2C-4BFC-B70E-61590F7628CDQ33697456-D75EA461-DF4B-444E-99F4-EB4AB41BB36EQ33742171-0F5347B9-B954-46B7-BE98-704298D7D2BEQ33771070-ED05298B-FDDD-45EC-88B8-1E8A24C858E5Q33918412-63663CA0-B5DC-4676-8A86-21D06E999232Q34013796-C2B47649-28FA-43F2-AEA1-924A09B4AE2EQ34060558-664A3A08-1A9F-46C4-AB7A-A22D7D7172F8Q34133706-48704680-75D4-4C59-B5B4-E36426DF2D4CQ34337117-A8C4A985-BE71-48B0-9A95-97FBAD4DCEDCQ34405013-92F57E62-3F48-484A-AEDE-F7DADFB5BDACQ35001132-AF2C51FA-AFFD-4951-95EE-0A2636A08C4FQ35011903-A8554369-C90F-4941-B3BB-5123E832E9C0Q35076298-A0481EAA-F6DA-4D66-87B5-AB5FA027DA0FQ35079955-DC52E5A0-E776-4485-93BF-3E99E4C1CEA5Q35311768-D2A1F1B6-AD3E-4941-A1F2-DCCDCDF2119BQ35806891-5B4A06B9-530B-4D08-9C29-308D97AB8CC4Q35821728-BC3B072F-BA66-408F-8FF3-CD78FE2BCD48Q35832904-C501FCE5-209B-478F-A141-05BCCFA2744CQ35856845-1CB1B18D-CE42-4F30-B5FF-7C24BF9EE184Q35898171-5A729D2C-ABDB-4ACC-BB1D-99971E160ACDQ35971808-F6B5E136-5679-4047-9222-D2131ADE6E8CQ36085799-7A9FBF85-E4E3-4987-B57D-C24A656868CDQ36179524-52EEEDCD-C450-4D53-875E-E7B5792A98C4Q36225879-707BDBB6-EAF1-46D7-9A27-D19E069ADF87Q36545185-A70E8836-8443-4B1D-B44D-FAF5DC8333A0Q37091635-D784B6DC-B104-4954-8BB5-6AC27ED1769CQ37132653-2CBEA693-5389-42EA-B0B8-A5EB4F2A7042Q37257390-0D39D590-FD5A-4455-89BC-8967D22AE2D8Q37277994-5EC5EF61-2E28-4D42-A4DA-CE1A41C565DDQ37341297-1260BA1C-1197-438D-BC86-9FF48060903DQ37362111-0C6E8931-45C0-43BD-B19D-C36A0F8F2BCA
P2860
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@en
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@nl
type
label
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@en
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@nl
prefLabel
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@en
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@nl
P2860
P1476
DNA methyltransferase and hist ...... of myelodysplastic syndromes.
@en
P2093
Elizabeth A Griffiths
Steven D Gore
P2860
P356
10.1053/J.SEMINHEMATOL.2007.11.007
P577
2008-01-01T00:00:00Z